{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "USD", "marketState": "REGULAR", "exchange": "PNK", "shortName": "APPILI THERAPEUTICS INC", "longName": "Appili Therapeutics Inc.", "messageBoardId": "finmb_330222442", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 0.0, "regularMarketPrice": 0.0267, "regularMarketChange": 0.0, "regularMarketTime": 1683899418, "regularMarketDayHigh": 0.0267, "regularMarketDayRange": "0.0267 - 0.0267", "regularMarketDayLow": 0.0267, "regularMarketVolume": 185, "regularMarketPreviousClose": 0.0267, "fullExchangeName": "Other OTC", "financialCurrency": "CAD", "regularMarketOpen": 0.0267, "averageDailyVolume3Month": 21596, "averageDailyVolume10Day": 32150, "fiftyTwoWeekLowChange": 0.001699999, "fiftyTwoWeekLowChangePercent": 0.06799996, "fiftyTwoWeekRange": "0.025 - 0.082", "fiftyTwoWeekHighChange": -0.055300005, "fiftyTwoWeekHighChangePercent": -0.67439026, "fiftyTwoWeekLow": 0.025, "fiftyTwoWeekHigh": 0.082, "earningsTimestamp": 1676377080, "earningsTimestampStart": 1687869000, "earningsTimestampEnd": 1688387400, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.07, "epsForward": -0.06, "epsCurrentYear": -0.07, "priceEpsCurrentYear": -0.38142857, "sharesOutstanding": 121266000, "bookValue": -0.044, "fiftyDayAverage": 0.02788, "fiftyDayAverageChange": -0.0011800006, "fiftyDayAverageChangePercent": -0.042324267, "twoHundredDayAverage": 0.03858, "twoHundredDayAverageChange": -0.011880001, "twoHundredDayAverageChangePercent": -0.3079316, "marketCap": 3625379, "forwardPE": -0.445, "priceToBook": -0.6068182, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1610116200000, "priceHint": 4, "displayName": "Appili Therapeutics", "symbol": "APLIF"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "#21-1344 Summer Street", "city": "Halifax", "state": "NS", "zip": "B3H 0A8", "country": "Canada", "website": "https://www.appilitherapeutics.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Appili Therapeutics Inc., a biopharmaceutical company, focuses on the acquisition and development of novel medicines for unmet needs in the infectious disease in Canada. Its anti-infective portfolio includes Favipiravir for pandemic influenza and COVID-19; ATI-2307, an antifungal candidate, which is in clinical stage for the treatment of cryptococcal meningitis and invasive candidiasis; ATI-1503 that develops a class of gram-negative targeting antibiotics; ATI-1501, a taste-masked liquid oral suspension formulation of an antibiotic, metronidazole; ATI-1801, a novel topical formulation of paromomycin for the treatment of cutaneous leishmaniasis; and ATI-1701 is a live-attenuated vaccine for Francisella tularensis. The company has a strategic alliance with AiPharma Global Holdings LLC for the development of Avigan/Reeqonus (favipiravir). Appili Therapeutics Inc. was incorporated in 2015 and is headquartered in Halifax, Canada.", "fullTimeEmployees": 8, "companyOfficers": [{"maxAge": 1, "name": "Dr. Donald D. Cilla Jr., M.B.A., Pharmd", "title": "CEO, Pres & Director", "fiscalYear": 2022, "totalPay": {"raw": 349510, "fmt": "349.51k", "longFmt": "349,510"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Kenneth G. Howling", "title": "Chief Financial Officer", "fiscalYear": 2022, "totalPay": {"raw": 761010, "fmt": "761.01k", "longFmt": "761,010"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Gary S. Nabors Ph.D.", "title": "Chief Devel. Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}